Mesothelial-To-Mesenchymal Transition as a Possible Therapeutic Target in Peritoneal Metastasis of Ovarian Cancer

Journal of Pathology - United States
doi 10.1002/path.4889
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cancer Metastasis: A Therapeutic Target

Journal of Oncology
Oncology
2019English

HIF-1α Mediates Hypoxia-Induced Epithelial–mesenchymal Transition in Peritoneal Mesothelial Cells

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2015English

Molecular Profiling Supports the Role of Epithelial-To-Mesenchymal Transition (EMT) in Ovarian Cancer Metastasis

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

RASAL2 Down-Regulation in Ovarian Cancer Promotes Epithelial-Mesenchymal Transition and Metastasis

Oncotarget
Oncology
2014English

MDM2 Promotes Epithelial–mesenchymal Transition and Metastasis of Ovarian Cancer SKOV3 Cells

British Journal of Cancer
Cancer ResearchOncology
2017English

Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis

Cancer Research
Cancer ResearchOncology
2019English

HSP70 Inhibits High Glucose-Induced Smad3 Activation and Attenuates Epithelial-To-Mesenchymal Transition of Peritoneal Mesothelial Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Downregulation of CHIP Promotes Ovarian Cancer Metastasis by Inducing Snail‐mediated Epithelial‐mesenchymal Transition

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis

Cancer Hallmarks
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy